Physician

Majdy Ali A. Albahhar, MD

According to 2025 Medicare claims, Majdy Albahhar, MD (NPI: 1013163211) practices dermatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is KANSAS MEDICAL CLINIC PA (NPI: 1508877523; TIN: 48-1203592) and primary practice location at 66112-1545.

Albahhar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,395 traditional Medicare patients, billed 7,514 HCPCS/CPT codes, and received $725,506 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,370 prescription claims across 521 beneficiaries totaling $823,944 in drug costs, led by Otezla (Apremilast). Open Payments data shows 131 records totaling $2,507. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $22,803 to $725,506. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,559 to $823,944. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	54	465	$22,803
2016	297	2,772	$131,115
2017	483	4,620	$251,426
2018	703	6,124	$374,355
2019	1,004	7,309	$471,584
2020	1,114	8,316	$555,177
2021	1,250	8,793	$810,371
2022	1,264	8,289	$653,417
2023	1,357	8,046	$634,470
2024	1,395	7,514	$725,506

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	40	$2,559
2016	136	320	$22,892
2017	207	558	$33,675
2018	292	924	$98,432
2019	310	961	$209,923
2020	332	1,006	$475,949
2021	325	989	$466,396
2022	286	876	$671,034
2023	396	1,184	$968,961
2024	521	1,370	$823,944

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	280	355	$456
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	604	803	$81
11102	Biopsy of related skin growth, first growth	310	368	$63
88305	Pathology examination of tissue using a microscope, intermediate complexity	920	1,604	$52
17000	Destruction of precancer skin growth, 1 growth	260	357	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	28	840	$138,626
Dupixent Pen	Dupilumab	28	910	$104,107
Dupixent Syringe	Dupilumab	12	532	$72,046
Clobetasol Propionate	Clobetasol Propionate	91	2,194	$6,828
Fluorouracil	Fluorouracil	31	899	$2,024

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	131	$2,507	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Majdy Ali A. Albahhar, MD?

Tedicare shows public-source Medicare data for Majdy Ali A. Albahhar, MD (NPI 1013163211), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Majdy Ali A. Albahhar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Majdy Ali A. Albahhar, MD?

Majdy Ali A. Albahhar, MD is linked to KANSAS MEDICAL CLINIC PA (billing NPI 1508877523) in the available physician profile data.

Does Majdy Ali A. Albahhar, MD have Open Payments data?

Majdy Ali A. Albahhar, MD has 131 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.